Epidemiological studies have reported that EGFR mutations occur in 40%–50% of nonsmoking NSCLC patients compared to 10%–15% in smokers, confirming smoking status as an independent predictive factor for EGFR mutations (37, 38). Here, EGFR is linked to non-small cell lung carcinoma.